Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1

European Journal of Paediatric Neurology

Volumn 8, Issue 3, 2004, Pages 121-129

  Kyllerman, Mårten ^a   Skjeldal, Ola ^b   Christensen, Ernst ^c   Hagberg, Gudrun ^a   Holme, Elisabeth ^d   Lönnquist, Tuula ^e   Skov, Liselotte ^c   Rotwelt, Terje ^b   von Döbeln, Ulrika ^f  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c Rigshospitalet   (Denmark)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dyskinesia; Dystonia; Glutaric aciduria type 1

Indexed keywords

BACLOFEN; CARNITINE; DIAZEPAM; GLUCOSE; GLUTARIC ACID; LEVODOPA; LYSINE; RIBOFLAVIN; TRYPTOPHAN; VALPROIC ACID; VIGABATRIN;

ARTICLE; BRAIN DISEASE; CEPHALOMETRY; CHILD; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DENMARK; DETERIORATION; DIET SUPPLEMENTATION; DISABILITY; DYSKINESIA; DYSTONIA; FEMALE; FINLAND; FOLLOW UP; GLUTARIC ACIDURIA TYPE 1; HEAD CIRCUMFERENCE; HUMAN; INBORN ERROR OF METABOLISM; MALE; MASS SCREENING; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NORWAY; ONSET AGE; OUTCOMES RESEARCH; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN RESTRICTION; RETROSPECTIVE STUDY; SIBLING; SPASTICITY; SPEECH; SURVIVAL RATE; SWEDEN;

EID: 2442646639     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpn.2003.12.007     Document Type: Article

References (26)

1. Goodman S, Markey SP, Moe PG, Miles BS, Teng CC. Glutaric aciduria a 'new' disorder of amino acid metabolism. Biochem Med 1975;12:12-21.
2. Hoffmann GF, Zschocke J. Glutaric aciduria type 1: from clinical, biochemical and molecular diversity to successful therapy. J Inher Metab Dis 1999;22:381-91.
3. Kyllerman M, Skjeldal HO, Lundberg M, et al. Dystonia and dyskinesia in glutaric aciduria type 1: clinical heterogeneity and therapeutic considerations. Mov disord 1994;9:22-30.
4. Hoffmann GF, Athanassopoulos S, Burlina AB, et al. Clinical course, early diagnosis, treatment and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 1996;27:115-23.
5. Bergman I, Finegold D, Gartner C, et al. Acute profound dystonia in infants with glutaric acidemia. Pediatrics 1989; 83:228-34.
6. Morton HD, Bennett MJ, Seargeant LE, Nichter CA, Kelley IK. Glutaric aciduria type 1: a common. cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster county, Pennsylvania. Am J Med Genet 1991;41: 89-95.
7. Niklasson A, Ericson A, Fryer JG, et al. An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand 1991;80:756-62.
8. Albertsson-Wikland K, Luo ZC, Niklasson A, Karlberg J. Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr 2002;91:739-54.
9. Christensen E, Ribes A, Busquets C, et al. Compound heterozygosity in the glutaryl-CoA dehydrogenase gene with R227P mutation in one allele is associated with no or very low free glutarate excretion. J Inher Metab Dis 1997; 20:383-6.
10. Pineda M, Ribes A, Busquets C, et al. Glutaric aciduria type 1 with high residual glutaryl-CoA dehydrogenase activity. Dev Med Child Neurol 1998;40:840-2.
11. Al-Essa M, Bakheet S, Patay Z, et al. Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in glutaric aciduria type 1: clinical and MRI correlations. Brain Dev 1998;20:295-301.
12. Bjugstad KB, Goodman SI, Freed CR. Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric aciduria type 1. J Pediatr 2000;137:681-6.
13. Baric I, Zschocke J, Christensen E, et al. Diagnosis and management of glutaric aciduria type 1. J Inher Metab Dis 1998;21:326-40.
14. Ullrich K, Flott-Rahmel B, Schluff P, et al. Glutaric aciduria type I: pathomechanisms of neurodegeneration. J Inherit Metab Dis 1999;22:392-403.
15. Kölker S, Mayatepek E, Hoffmann GF. White matter disease in cerebral organic disorders: clinical implications and suggested pathomechanisms. Neuropediatrics 2002;33: 225-31.
16. Greenberg CR, Prasad AN, Dilling LA, et al. Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric aciduria type I in Manitoba and Northwestern Ontario, Canada. Mol Genet Metab 2002;75:70-8.
17. Kölker S, Ramaekers V, Zschocke J, Hoffman GF. Acute encephatopathy despite early therapy in a patient with homozygosity for E365K in the glutaryl-coenzyme A dehydrogenase gene. J Pediatr 2001;138:277-9.
18. Monavari AA, Naughton ER. Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management. Arch Dis Child 2000;82:67-70.
19. Superti-Furga A. Hoffmann GF., Glutaric aciduria type 1 (glutaryl-CoA-dehydrogenase deficiency): advances and unanswered questions. Report from an international meeting. Eur J Pediatr 1997;156:821-8.
20. Superti-Furga A. Glutaric aciduria type 1 and neonatal screening: time to proceed-with caution. Eur J Pediatr 2003;162(Suppl. 1):S17-S20.
21. Busquets C, Merinero B, Christensen E, et al. Glutaryl-CoA dehydrogensase (GCDH) deficiency in Spain: evidence of two groups of patients, genetically and biochemically distinct. Pediatr Res 2000;48:315-22.
22. Schwarz M, Christensen E, Superti-Furga A, Brandt NJ. The human glutaryl-CoA dehydrogenase gene: report of intronic sequences and of 13 novel mutations causing glutaric aciduria type 1. Hum Genet 1998;102:452-8.
23. Zschocke J, Quak E, Guldberg P, Hoffmann GF. Mutation analysis in glutaric aciduria type 1. J Med Genet 2000;37: 177-81.
24. Hauser SE, Boneh A. Severe clinical course with recurrent hyperpyrexia in a patient with glutaric aciduria type 1. Neuropediatrics 1999;30:51-2.
25. Hagberg B. Emotionally released hyperthermia in cerebral palsy. Neuropädiatrie 1970;3:295-306.
26. Emanuelson I, von Wendt L, Kyllerman M. Clinical outcome after near-fatal late shunt complication in hydrocephalus. Childs Nerv Syst 1994;10:270-4.